Doctor profile · Federal record
Dr. Mark Turrill, M.D.
Hematology & Oncology Physician (CMS: Medical Oncology) · Hematology (Internal Medicine) Physician · Medical Oncology Physician · Lakeport, CA
- NPI 1568542314
- Accepts Medicare
- 38 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
5150 Hill RD E Ste F
Lakeport, CA 954535100
(707) 262-3060
fax (707) 262-3062 - Mailing address
-
5150 Hill RD Ste F
Lakeport, CA 954535100
Credentials & registration
- NPI registered
- October 2006 — 20 yrs on file
- Profile last updated
- November 11, 2021
- Year of graduation
- 1988 — 38 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- California #G66868
- Medicaid
- CA #00G668680
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1568542314. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
48,396
Distinct HCPCS
10
Medicare allowed
$627,864
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 15,942 | 16 | $3 | |
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 14,280 | 12 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 10,863 | 47 | $23 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 1,497 | 506 | $8 | |
36415 |
Insertion of needle into vein for collection of blood sample | 1,379 | 500 | $8 | |
J2405 |
Injection, ondansetron hydrochloride, per 1 mg | 976 | 17 | $0 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 860 | 14 | $0 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 750 | 378 | $182 | |
96372 |
Injection of drug or substance under skin or into muscle | 307 | 72 | $15 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 307 | 224 | $131 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 2,104. This provider delivers 23× the peer median.Open Payments
Industry payments received
All-time total
$262
Transactions
12
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Celgene Corporation | 4 | $76.41 | |
| Alexion Pharmaceuticals, Inc. | 2 | $53.02 | |
| Saluda Medical Americas, Inc. | 1 | $27.56 | |
| Rigel Pharmaceuticals, Inc. | 1 | $23.97 | |
| SERVIER PHARMACEUTICALS LLC | 1 | $23.93 | |
| GlaxoSmithKline, LLC. | 1 | $23.75 | |
| AstraZeneca Pharmaceuticals LP | 1 | $17.27 | |
| PFIZER INC. | 1 | $15.83 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
920
Patients
160
Total drug cost
$807,833
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 185 | 40 | $4,342 |
| Levothyroxine Sodium | Generic | 72 | 17 | $1,009 |
| Letrozole | Generic | 66 | 16 | $1,083 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 62 | 18 | $1,625 |
| Prednisone | Generic | 62 | 17 | $665 |
| Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) | Brand | 56 | 15 | $1,880 |
| Gabapentin | Generic | 55 | 13 | $982 |
| Abiraterone Acetate | Generic | 54 | 11 | $130,443 |
| Hydroxyurea | Generic | 52 | 0 | $1,565 |
| Bicalutamide | Generic | 45 | 0 | $1,264 |
Hospital affiliations
Frequently asked questions
What is Dr. Mark Turrill's medical specialty?
Dr. Mark Turrill practices Hematology & Oncology Physician in Lakeport, CA.
Where does Dr. Mark Turrill practice?
Dr. Mark Turrill practices at 5150 Hill RD E Ste F, Lakeport, CA 954535100. Office phone: 7072623060.
What is Dr. Mark Turrill's NPI?
Dr. Mark Turrill's National Provider Identifier (NPI) is 1568542314, issued by NPPES.
Does Dr. Mark Turrill accept Medicare assignment?
Yes. Dr. Mark Turrill accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mark Turrill commonly perform?
Top Medicare-reported procedures in 2023: Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881); Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.